Search results
Inhibrx's Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge
Benzinga via Yahoo Finance· 2 years agoBased on discussions with the FDA, Inhibrx Inc (NASDAQ: INBX) has the potential to pursue...
Mereo BioPharma Shares Jump After Encouraging Alvelestat Data In Lung Disease
Benzinga via Yahoo Finance· 2 years agoMereo BioPharma Group plc (NASDAQ: MREO) has announced topline efficacy and safety results from...
Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
Zacks via Yahoo Finance· 3 months agoSanofi (SNY) will acquire Inhibrx (INBX) for nearly $2.2 billion. Post-acquisition, it will retain...
Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 8 months agoWave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good...
Inhibrx's INBRX-101 Shows Favorable Safety Profile In An Inherited Disorder
Benzinga via Yahoo Finance· 2 years agoInhibrx Inc (NASDAQ: INBX) announced topline results from a Phase 1 clinical trial of INBRX-101, an...
Why Did BMO Capital Markets Raise Price Target For Gene Stock One Month After Initiating Coverage
Benzinga via Yahoo Finance· 2 years agoBMO Capital Markets has raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $61 from...
Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?
Zacks via Yahoo Finance· 3 months agoIntellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company focused on developing...
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
Motley Fool· 5 months agoOn Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge...
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Motley Fool· 7 months agoOf course, it's complicated to figure out which are going to soar and which will languish, so it...
Vertex Pharmaceuticals' (VRTX) New AAT Corrector Enters Clinic
Zacks via Yahoo Finance· 2 years agoThe FDA clears Vertex's (VRTX) Investigational New Drug application for VX-634, a small molecule AAT...